Clinical Trial Update: Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC) [Phase 3]

View source ↗

Summary

Phase 3 trial update for seladelpar in primary biliary cholangitis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Seladelpar (seladelpar)

Snippet

Sponsor: Gilead Sciences | Conditions: Primary Biliary Cirrhosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING